Evolve BioSystems Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 47
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $65M
Latest Deal Amount
  • Investors
  • 15

Evolve BioSystems General Information

Description

Developer of microbiome-based products designed to establish, restore and maintain a healthy gut microbiome. The company's products focus on solving gut dysbiosis throughout the human life cycle as well as in various animal species, enabling physicians to maintain the healthy gut microbiome in newborn infants with a consumer-directed home use product, and a hospital-based neonatal ICU product.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Other Pharmaceuticals and Biotechnology
Other Healthcare
Primary Office
  • 2121 2nd Street
  • Suite C108
  • Davis, CA 95618
  • United States
+1 (530) 000-0000

Evolve BioSystems Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Evolve BioSystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 25-May-2021 $65M 00000 00000 Completed Generating Revenue
6. Debt - PPP 11-Jun-2020 00000 0000 Completed Generating Revenue
5. Later Stage VC (Series C) 12-Jun-2018 0000 0000 00000 Completed Generating Revenue/Not Profitable
4. Later Stage VC (Series B) 30-May-2017 0000 0000 0000 Completed Generating Revenue/Not Profitable
3. Later Stage VC (Series A) 17-Aug-2015 000 0000 0000 Completed Startup
2. Seed Round 15-Sep-2014 $1M $1M 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Evolve BioSystems’s complete valuation and funding history, request access »

Evolve BioSystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D-2 000,000 00.000000 00.00 000.00 000.00 00 000.00 0.000
Series D-1 0,000,000 00.000000 00.00 000.00 000.00 00 000.00 00.000
Series C 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 2,091,709 $0.000100 $0.34 $4.3 $4.3 1x $4.3 10.57%
Seed 725,098 $0.000100 $0.11 $1.32 $1.32 1x $1.32 3.66%
To view Evolve BioSystems’s complete cap table history, request access »

Evolve BioSystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of microbiome-based products designed to establish, restore and maintain a healthy gut microbiome. The company
Biotechnology
Davis, CA
47 As of 2021
00000
0000 0000-00-00
00000000000 00000

0000000

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercita
0000 000000000
Lexington, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000 00000000
Duarte, CA
000 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Evolve BioSystems Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kaleido BioSciences Formerly VC-backed Lexington, MA 00 00000 00000000 00000
00000000 000000000 Venture Capital-Backed Duarte, CA 000 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed New York, NY 00 00000 00000000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000 Formerly VC-backed Ness Ziona, Israel 000 00000 000000000 00000
You’re viewing 5 of 7 competitors. Get the full list »

Evolve BioSystems Patents

Evolve BioSystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200206732-A1 Methods and apparatus for collecting and testing solid or semi-solid materials Pending 31-Dec-2018 00000000000
US-20210161924-A1 Novel oligosaccharides for use in prebiotic applications Pending 19-Jun-2018 0000000000
EP-3801067-A1 Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires Pending 01-Jun-2018 0000000000
US-20210308196-A1 Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires Pending 01-Jun-2018 0000000000
US-20200345055-A1 Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains Pending 17-Jan-2018 C12N1/20
To view Evolve BioSystems’s complete patent history, request access »

Evolve BioSystems Executive Team (12)

Name Title Board Seat Contact Info
Timothy Brown Chief Executive Officer & Board Member
Sandy Argabrite Chief Financial Officer
David Kyle Ph.D Co-Founder , Executive Chairman & Chief Scientific Officer
Samara Freeman Ph.D Co-Founder & Director, Intellectual Property & Regulatory Affairs
Christie Fleming Senior Vice President, Sales & Marketing
You’re viewing 5 of 12 executive team members. Get the full list »

Evolve BioSystems Board Members (10)

Name Representing Role Since
David Kyle Ph.D Evolve BioSystems Co-Founder , Executive Chairman & Chief Scientific Officer 000 0000
Gareth Asten Acre Venture Partners Board Member 000 0000
Patrick Zhang Horizons Ventures Board Member 000 0000
Roger Wyse Ph.D Spruce Capital Partners Board Member 000 0000
Simon Barnes Ph.D Tate & Lyle Ventures Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Evolve BioSystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evolve BioSystems Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cargill Corporation Minority 000 0000 000000 0
iSelect Fund Venture Capital Minority 000 0000 000000 0
Manna Tree Partners Asset Manager Minority 000 0000 000000 0
Spur Capital Partners Fund of Funds Minority 000 0000 000000 0
Arla Foods Corporation Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »